Palumbo Wealth Management LLC Akero Therapeutics, Inc. Transaction History
Palumbo Wealth Management LLC
- $308 Million
- Q2 2025
A detailed history of Palumbo Wealth Management LLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Palumbo Wealth Management LLC holds 4,910 shares of AKRO stock, worth $266,760. This represents 0.08% of its overall portfolio holdings.
Number of Shares
4,910Holding current value
$266,760% of portfolio
0.08%Shares
1 transactions
Others Institutions Holding AKRO
# of Institutions
272Shares Held
86MCall Options Held
1.02MPut Options Held
823K-
Rtw Investments, LP New York, NY7.42MShares$403 Million4.92% of portfolio
-
Janus Henderson Group PLC London, X07.07MShares$384 Million0.16% of portfolio
-
Wellington Management Group LLP Boston, MA5.94MShares$323 Million0.05% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$304 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$284 Million7.15% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.52B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...